Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim
Authors:
- Yoko KatsunoYKYoko Katsuno
- Shogo EhataSEShogo Ehata
- Kohei MiyazonoKMKohei Miyazono
- 22 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 149 (1) , 55-65
Abstract
Cancer cells undergo multi-step processes in obtaining the ability to metastasize, and are constantly exposed to signals that induce apoptosis. Acquisition of anti-apoptotic properties by cancer cells is important for metastasis, and recent studies suggest that transforming growth factor (TGF)-β promotes the survival of certain types of cancer cells. Here, we found that in highly metastatic breast cancer cells, JygMC(A), JygMC(B) and 4T1, TGF-β ligands were produced in autocrine fashion. Pharmacological inhibition of endogenous TGF-β signalling by a TGF-β type I receptor kinase inhibitor in serum-free conditions increased the expression of BH3-only protein, Bim (also known as Bcl2-like 11) in JygMC(A) and JygMC(B) cells, and caused apoptotic cell death. We also found that induction of Bim by TGF-β was not observed in Foxc1 knocked-down cancer cells. These findings suggest that TGF-β plays a crucial role in the regulation of survival of certain types of cancer cells through the TGF-β-Foxc1-Bim pathway, and that specific inhibitors of TGF-β signalling might be useful as apoptosis inducers in breast cancer cells.Keywords
This publication has 47 references indexed in Scilit:
- Bone morphogenetic protein receptors and signal transductionThe Journal of Biochemistry, 2009
- FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformationNature Genetics, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- BH3-only proteins in apoptosis and beyond: an overviewOncogene, 2008
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Cell type-specific DNA methylation patterns in the human breastProceedings of the National Academy of Sciences, 2008
- TGFβ in CancerCell, 2008
- Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell lineCancer Science, 2006
- Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase InhibitorCancer Research, 2006
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004